contact@purec.jp

PuREC, a clinical-stage biotech startup with unique MSC cell therapy “REC”, has raised JPY 7.0 billion ($5.8 million) with third-party...

We are delighted to have been awarded with JETRO Kyoto Award at 3rd Kyoto University Life Science Showcase @ San Diego 2022. Event...

We are happy to announce that PuREC is invited to Genesis 2021 Innovation Workshop speaker at LINK-J session. Genesis 2021 Innovation...

We are happy to announce that PuREC is selected one of the 8 finalists at the Japan Healthcare Venture Summit (JHVS) global pitch on 16...

A phase I/IIa clinical trial for hypophotase treatment has started in collaboration with Shimane University. This First in Human trial is...

PuREC has started a joint research project with Hokkaido University and Mochida Pharmaceutical to developnew treatments for spinal...

PuREC’s Morishita took the stage at "Japan Healthcare Venture Summit 2020" [October 14th to 16th] to present the company’s "90 seconds...